James P. LaPolla

<i>BRCA1</i> and <i>BRCA2</i> mutations account for a large proportion of ovarian carcinoma cases

Tuya Pal, Jenny Permuth‐Wey, Judith A. Betts et al. · Cancer · 2005 · 688 citations

Lysophospholipids Are Potential Biomarkers of Ovarian Cancer

Rebecca Sutphen, Yan Xu, George D. Wilbanks et al. · Cancer Epidemiology Biomarkers & Prevention · 2004 · 336 citations

Ovarian Transposition in Cervical Cancer

Barrie Anderson, James P. LaPolla, Deborah Turner et al. · Gynecologic Oncology · 1993 · 129 citations

Infertility, Cervical Cancer, Gynecology +5

The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma

James P. LaPolla, John B. Schlaerth, Otis Gaddis et al. · Gynecologic Oncology · 1986 · 128 citations

Intraoperative Consultation, Gynecologic Surgery, Surgical Oncology +12

Upper-body fat distribution and endometrial cancer risk.

David V. Schapira, Nagi B. Kumar, Gary H. Lyman et al. · PubMed · 1991 · 105 citations